Bernhardt G. Zeiher - 14 Mar 2024 Form 3 Insider Report for Amylyx Pharmaceuticals, Inc. (AMLX)

Role
Director
Signature
/s/ Joshua B. Cohen, as Attorney in Fact
Issuer symbol
AMLX
Transactions as of
14 Mar 2024
Net transactions value
$0
Form type
3
Filing time
15 Mar 2024, 16:31:36 UTC
Previous filing
04 Apr 2023
Next filing
07 Jun 2024

No securities are beneficially owned.

Remarks:

Exhibit 24.1 - Power of Attorney